Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. Eurofins is a global leader in food, environment, and pharmaceutical product testing.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

Leafwell

DECEMBER 4, 2020

One of the greatest promises of medical cannabis is the hope that cannabidiol (CBD) products extend to people suffering from anxiety. CBD products are perceived as a safer, less toxic option to pharmaceutical chemicals in treating conditions related to anxiety disorders.

CBD 60

CBD Pharmaceutical Conditions Cannabis 60

CannaMD

FEBRUARY 19, 2020

Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD.

CBD 92

CBD Pharmaceutical Research and Development Conditions 92

Cannabis Law Report

AUGUST 24, 2021

BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

Cannabis Law Report

AUGUST 20, 2021

Although studies have shown that CBD can be beneficial for improving conditions like spasms, anxiety disorders, and pains, there are still several grey areas that the researchers are trying to figure out. However, veterinary studies have shown that CBD can be beneficial for relieving the same symptoms in animals like cats and dogs.

CBD 105

CBD Pets Pharmaceutical Conditions 105

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

FloridaMarijuana.net

JUNE 19, 2018

When family members are sick or suffering, its natural to seek relief for their conditions and ailments. Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. CBD (cannabidiol) is the non-psychoactive ingredient in cannabis.

Pets 186

Pets CBD Tincture Oil 186

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. CBD does not give its users the ‘high’ typically associated with Cannabis. In this article, we’ll tell you what some of the top health benefits of CBD products are: Mental Health Disorders. Analgesic Effects.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Veriheal

AUGUST 9, 2023

In the new yet-to-be-published study, researchers led by Rodrigo Moura Neto, a Molecular Biologist at the Federal University of Rio de Janeiro, discovered a CBD-like compound in Trema micrantha, a common plant in Brazil. Presently, CBD is inarguably the most acceptable compound in cannabis.

CBD 78

CBD Cannabinoids THC Extraction 78

Cannabis Law Report

DECEMBER 1, 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator MYMD-1 and synthetic cannabidiol derivative Supera-CBD. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About Supera-CBD. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. Livestream: Click here.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JULY 9, 2021

In recent years, products containing cannabidiol otherwise referred to as CBD, have become increasingly popular as a natural remedy for a variety of common ailments. . Even though CBD comes from the same plant as tetrahydrocannabinol (THC), it is not a psychoactive compound so therefore it will not create a sensation of feeling ‘high’.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

PrestoDoctor

DECEMBER 12, 2023

Additionally, cannabis has shown promise in easing symptoms of chronic conditions such as arthritis, insomnia, and anxiety. Additionally, using cannabis for medical conditions does not mean THC must be consumed. CBD also plays an important role in management of conditions without the psychoactive high.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

SEPTEMBER 22, 2021

The terms of the Agreement provide OCT with an exclusive worldwide licence to the entire cannabinoid derivative library, including 335 derivatives of cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG), intellectual property rights including 14 patent families and associated product research and development (“Canopy Library”).

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

SpeedWeed

APRIL 9, 2021

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals. This law allows a limited number of patients to use CBD-based medicine with no more than 0.5 percent THC content. View original article.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Cannabis Law Report

AUGUST 29, 2021

This shipment also marks the 11 th country to which SMGH has exported the Aureus™ branded products, which include a range of CBD, THC and CBG extracts and feminized seeds. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. About Avicanna.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Canna Law Blog

JANUARY 11, 2023

Notoriously, tech giants like Instagram and Facebook would take down cannabis-related ad content for violating site terms and conditions around the promotion of illegal substances and recreational drugs. However, Google recently has decided to relax its advertising policies– at least around hemp and hemp CBD products.

Policy 68

Policy CBD Supply Chain Compliance 68

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 98

CBD THC Conditions Medicine 98

The Cannigma

JUNE 15, 2021

Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

OCTOBER 5, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it will present at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on Thursday, October 7, 2021.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. What do experts say?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. MyMD also holds three patents for its synthetic cannabidiol (CBD) derivative Supera-CBD.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

MJ Business Attorneys

JUNE 29, 2018

Food and Drug Administration (FDA) approved Epidiolex, a drug containing Cannabidiol (CBD). The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Dykema (Cannabis Law Blog)

DECEMBER 7, 2022

The Food and Drug Administration (FDA) issued warning letters to five companies late last month on Monday, November 21, 2022, claiming that they are illegally selling products containing cannabidiol (CBD). The companies targeted are 11-11-11 Brands, CBD American Shaman LLC, Infusionz LLC, Naturally Infused LLC, and Newhere Inc.

CBD 85

CBD Food Consumption Policy 85

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. MyMD also holds two patents for its synthetic cannabidiol (CBD) derivative Supera-CBD.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Veriheal

MARCH 18, 2021

While around 95% of all lab animals are mice and rats , a weird, but enlightening, new scientific study decided to make use of aging cats in order to better understand CBD and Alzheimer’s disease. They needed a model for Alzheimer’s disease in order to effectively review cannabidiol (CBD) as a potential treatment. Why Aging Cats?

CBD 82

CBD Research and Development Pets Treatment 82

Cannabis Law Report

OCTOBER 19, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 4:30 p.m.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Otherside Farms

MARCH 2, 2021

CBD, or Cannabidiol, is one of nearly 200 compounds found in the cannabis/marijuana plant. CBD is quite different when compared to THC, or tetrahydrocannabinol, which is the psychoactive compound in cannabis that makes people feel high. CBD, on the other hand, doesn’t give off any high feelings since it lacks psychoactive properties.

CBD 52

CBD Chronic Pain Topical Conditions 52

Cannabis Law Report

AUGUST 23, 2021

Analysts predict that pet-and-animal product sales are among the fastest-growing sectors in the CBD market with estimated sales reaching $125 million by 2022. The basics on CBD, hemp and the 2018 Farm Bill. Are any CBD and hemp-containing products legal for use in pet products? WRITTEN BY: Womble Bond Dickinson.

Pets 105

Pets Hemp CBD Food 105